ASIA PACIFIC OPIOIDS DRUGS MARKET FORECAST 2019-2028

ASIA PACIFIC OPIOIDS DRUGS MARKET FORECAST 2019-2028

  • May 2020 •
  • 120 pages •
  • Report ID: 5893079 •
  • Format: PDF
KEY FINDINGS
The Asia Pacific opioids drugs market is estimated to record a CAGR of 3.02% over the forecast period, 2019-2028. The surge in palliative care for patients undergoing intense suffering, is one of the significant factors driving market growth in the region.

MARKET INSIGHTS
The growth rate of the Asia Pacific opioids drugs market is further analyzed by dividing the region into respective countries such as Vietnam, Thailand, Japan, Australia &New Zealand, China, Indonesia, India, South Korea, and the rest of Asia Pacific that includes Singapore, Philippines, among others.In Indonesia, the use of opioids for cancer patients is very low due to the inability to assess pain and dose correctly, and fear of addiction.

The country has taken positive steps to avoid opioids overdose and infectious diseases, such as opioid substitution therapy, needle, and syringe programs, and increased access to HIV treatment.Due to COVID-19, Indonesia has restricted the import of opioid drugs.

In countries like Thailand, cancer is one of the critical health issues.But there are several issues in cancer pain management.

The healthcare society is reluctant to validate opioid analgesics for fear of addiction.
In Vietnam, drug users increased by 16% in 2016, in comparison to 2015.The government implemented a project with a budget of $xx to improve and combine information and mass communication campaigns with community-based activities for the prevention of drug abuse.

Australia spent 9.1% of its GDP on healthcare in 2017. There are several organizations that create pain awareness in the country, as one in five Australians live with chronic pain, including children and adolescents. Such awareness programs can help people to understand the usage of opioid medication. In the rest of Asia Pacific countries, there is an urgent need to precisely form policies to increase access to opioid medication that include palliative care.

COMPETITIVE INSIGHTS
Sun Pharmaceuticals Industries Ltd, Johnson & Johnson, Lupin Ltd, Pfizer Inc, Teva Pharmaceutical Industries Ltd, etc. are some of the prominent companies functioning in the market.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ACURA PHARMACEUTICALS INC
2. ALLERGAN PLC
3. BIODELIVERY SCIENCES INTERNATIONAL INC
4. CIPHER PHARMACEUTICALS INC
5. COLLEGIUM PHARMACEUTICAL INC
6. DAIICHI SANKYO INC
7. EGALET CORP
8. HIKMA PHARMACEUTICALS PLC
9. INDIVIOR INC
10. JANSSEN PHARMACEUTICALS INC
11. JOHNSON & JOHNSON
12. LANNETT CO. INC
13. LUPIN LTD
14. MYLAN NV
15. PFIZER INC
16. PURDUE PHARMA LP
17. SANOFI-AVENTIS S.A
18. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
19. TEVA PHARMACEUTICAL INDUSTRIES LTD